JPRN-UMIN000003883招募中2 期
Phase II study of nedaplatin plus docetaxel in patients with advanced squamous cell lung cancer pretreated with platinum-based chemotherapy. - Phase II study of nedaplatin plus docetaxel in patients with advanced squamous cell lung cancer pretreated with platinum-based chemotherapy.
Shizuoka Cancer Center, Thoracic Oncology Division0 个研究点目标入组 28 人开始时间: 2010年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2) symptomatic brain metastasis 3) steroid treatment 4) massive pleural effusion or pericardial effusion 5) active infection 6) history of active double cancer 7) history of severe drug allergy 8) uncontrollable diabetes mellitus 9) HBs antigen 10) history of pregnancy or lactation 11) history of active psychological disease 12) severe drug allergy for 80 polysorbate content medicine 13) any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
研究者
相似试验
已完成
1 期
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-fluorouracil Treatmentesophageal squamous cell carcinomaJPRN-UMIN000010561niversity of Toyama12
招募中
2 期
The Phase II Study of Docetaxel plus Nedaplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000004634Shiga University of Medical Science30
已完成
不适用
Phase I/II study of docetaxel/nedaplatin/5-FU for advanced esophageal cancerEsophageal cancerJPRN-UMIN000006615Chiba University40
招募中
不适用
A Phase II trial of Nedaplatin, 5FU and Docetaxel for induction chemotherapy with Local advanced squamous cell carcinoma of the Head and Neckocal advanced squamous cell carcinoma of the Head and NeckJPRN-UMIN000022191Kindai nara hospital30
已完成
1 期
Phase 1/2 study of the combination of nedaplatin and ifosfamide in patients with advanced or recurrent cervical cancerAdvanced or recurrent cervical cancerJPRN-UMIN000000464Graduate School of Medicine, Chiba University25